Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 56%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is poised for continued success due to its strong positioning in the large-cap MedTech industry and its steady growth in orthopedic end-markets. The company's positive outlook is supported by its diversified product portfolio, strong demand for its capital products, and its presence in attractive end-markets. While the recent cyberattack may have caused some disruption, it is likely to be recuperated in the second half of the year. Furthermore, Stryker's presence in the international market also provides potential for future growth. However, potential risks to this positive outlook include slower-than-expected adoption within the ASC setting, potential declines in growth from mature product cycles, and increasing competition from orthopedic robotic systems. Despite these risks, Stryker remains well-positioned for future success and offers a positive risk/reward profile for investors.

Bears say

Stryker is a leader in the medical technology industry with a strong competitive position in reconstructive orthopedic implants and operating room equipment. However, slowing momentum from recent product cycles and potential disruptions from a recent cyberattack may limit near-term performance. Furthermore, a lack of execution related to strategic M&A and slower-than-expected adoption within the ASC setting create downside risks to Stryker’s long-term growth potential. As such, the fundamental reasons behind our negative outlook are the potential for slower growth and execution issues, which could impact the company’s financial performance and investor sentiment.

Stryker (SYK) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 56% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 18 analysts, Stryker (SYK) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $385.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $385.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.